|
|
Volumn 226, Issue 1-2, 2002, Pages 187-198
|
|
Antidiabetic vanadium(IV) and zinc(II) complexes
|
|
Author keywords
Adipocytes; Diabetes mellitus; Insulin mimetic activity; Vanadium(IV) complexes; Zinc(II) complexesStructure activity relationship
|
|
Indexed keywords
ANTIDIABETIC AGENT;
BIS(1 OXY 2 PYRIDINETHIOLATO)OXOVANADIUM COMPLEX;
BIS(3 METHYLPICOLINATO)OXOVANADIUM COMPLEX;
BIS(4 CHLOROPICOLINATO)OXOVANADIUM COMPLEX;
BIS(5 IODOPICOLINATO)OXOVANADIUM COMPLEX;
BIS(6 METHYLPICOLINATO)OXOVANADIUM COMPLEX;
BIS(6 METHYLPICOLINATO)ZINC COMPLEX;
BIS(ETHYLMALTOLATO)OXOVANADIUM COMPLEX;
BIS(MALONATO)OXOVANADIUM COMPLEX;
BIS(MALTOLATO)OXOVANADIUM COMPLEX;
BIS(MALTOLATO)ZINC COMPLEX;
BIS(METHYLCYSTEINATO)OXOVANADIUM COMPLEX;
BIS(OXALATO)OXOVANADIUM COMPLEX;
BIS(PICOLINATO)OXOVANADIUM COMPLEX;
BIS(PICOLINATO)ZINC COMPLEX;
BIS(PYRROLIDINE N CARBODITHIOLATO)OXOVANADIUM COMPLEX;
BIS(SALICYLALDEHYDE)OXOVANADIUM COMPLEX;
BIS(TARTRATO)OXOVANADIUM COMPLEX;
BIS(THREONYL)ZINC COMPLEX;
INSULIN DERIVATIVE;
N,N' ETHYLENEBIS(GLYCINATO)ZINC COMPLEX;
N,N' ETHYLENEBIS(SARCOSINATO)ZINC COMPLEX;
N,N' TRIMETHYLENEBIS(GLYCINATO)ZINC COMPLEX;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANADIUM DERIVATIVE;
ZINC CHLORIDE;
ZINC COMPLEX;
ZINC ION;
ZINC SULFATE;
ATHEROSCLEROSIS;
CONFERENCE PAPER;
DIABETIC MICROANGIOPATHY;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG DISPOSITION;
DRUG DISTRIBUTION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SYNTHESIS;
ELECTRON SPIN RESONANCE;
HEART DISEASE;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
INSULIN DEPENDENT DIABETES MELLITUS;
NEUTRON ACTIVATION ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
STREPTOZOCIN DIABETES;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
|
|
EID: 0036192909
PISSN: 00108545
EISSN: None
Source Type: Journal
DOI: 10.1016/S0010-8545(01)00447-7 Document Type: Conference Paper |
|
Times cited : (507)
|
|
References (78)
|
